Classification of Crohn’s Disease and Inflammatory Bowel Disease Surgery-Related Fistulae


List of Abbreviations

CD

Crohn's disease

CTE

Computed tomography enterography

ECF

Enterocutaneous fistula

EEF

Enteroenteric fistula

EUA

Examination under anesthesia

EUS

Endoscopic ultrasound

MRE

Magnetic resonance enterography

RVF

Rectovaginal fistula

Introduction

Fistulae occur in 14%–50% of all patients with Crohn's disease (CD). In a population-based study from Olmsted County, Minnesota, 35% of CD patients had at least one fistula. Perianal fistulae comprise at least half of all cases, enteroenteric fistula (EEF) 25%, rectal/anovaginal 10%, and others such as enterocutaneous fistula (ECF) and enterovesical account for 10%–15% of the fistulas. Over a 20-year follow-up, two-thirds of patients experience only one fistula episode whereas the remainder will have two or more related episodes. Of note, the presence of a fistula is an indicator of more aggressive disease that may require more frequent hospitalizations, higher incidence of surgery, and increased utilization of corticosteroid treatment. The diagnosis, assessment, and the treatment of fistulizing CD is complex and mandates a multidisciplinary approach involving gastroenterologists, surgeons, and radiologists at a specialized referral center.

Definitions

A fistula is defined as a pathological connection adjoining two epithelialized surfaces. They can connect a portion of the intestine to the outer surface (e.g., enteroatmospheric or anus to outer skin) or to another inner surface (e.g., enteroenteric, enterovesicular).

Pathophysiology

Despite the prevalence of fistulae in patients with CD, the pathophysiology remains largely unknown. The first step in the formation of a fistula is thought to be tissue destruction from transmural inflammation. The impaired ability of mucosal fibroblasts to migrate toward the area of tissue injury, and the inability of fibroblasts to repair mucosal defects may stimulate the migration of epithelial cells toward the defect. For faster migration, epithelial cells undergo epithelial-mesenchymal cell transition and develop a mesenchymal cell-like phenotype with loose cell to cell contacts, invasive potential, and downregulated apoptotic pathways which may penetrate into the bowel and lead to fistula formation. However, the exact mechanism has yet to be defined.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here